Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis

Journal of Clinical Investigation

Volumn 104, Issue 7, 1999, Pages 975-982

  Calapai, Gioacchino ^a   Corica, Francesco ^a   Corsonello, Andrea ^a   Sautebin, Lidia ^b   Di Rosa, Massimo ^b   Campo, Giuseppe M ^a   Buemi, Michele ^a   Mauro, Vittorio Nicita ^a   Caputi, Achille P ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ARGININE; DEXTRO ARGININE; LEPTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEROTONIN; TRYPTOPHAN;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARTICLE; CONTROLLED STUDY; DIENCEPHALON; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD INTAKE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; TRYPTOPHAN BRAIN LEVEL; WEIGHT GAIN;

EID: 0032718692     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5867     Document Type: Article

References (56)

1. Zhang, Y., et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
2. Flier, J.S. 1997. Leptin expression and action: new experimental paradigms. Proc. Natl. Acad. Sci. USA. 94:4242-4245.
3. Pelleymounter, M.A., et al. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540-543.
4. Tritos, N.A., and Mantzoros, C.S. 1997. Leptin: its role in obesity and beyond. Diabetologia. 40:1371-1379.
5. Auwerx, J., and Staels, B. 1998. Leptin. Lancet. 351:737-742.
6. Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R., and Burn, P. 1995. Recombinant mouse Ob protein; evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-549.
7. Stephens, T.W., et al. 1995. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:530-532.
8. Baumann, H., et al. 1996. The full length leptin receptor has signalling capabilities of interleukin 6-type receptors. Proc. Natl. Acad. Sci. USA. 93:8374-8378.
9. Montague, C.T., et al. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:903-908.
10. Tartaglia, L.A., et al. 1995. Identification and expression cloning of a leptin receptor, Ob-R. Cell. 83:1263-1271.
11. Lee, G.H., et al. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:632-635.
12. Chen, H., et al. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84:491-495.
13. Schwartz, M.W., et al. 1996. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes. 45:531-535.
14. Erickson, J.C., Clegg, K.E., and Palmiter, R.D. 1996. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:415-421.
15. Garthwaite, J., Charles, S.L., and Chess-Williams, R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature. 336:385-388.
16. Garthwaite, J., and Boulton, C.L. 1995. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:683-706.
17. Calapai, G., et al. 1992. Evidence that nitric oxide modulates drinking behaviour. Neuropharmacology. 31:761-764.
18. Morley, J.E., and Flood, J.F. 1991. Evidence that nitric oxide modulates food intake in mice. Life Sci. 49:707-711.
19. G-nitro-L-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. Eur. J. Pharmacol. 230:125-128.
20. Wang, M.Y., Koyama, K., Shimabukuro, M., Newgard, C.B., and Unger, R.H. 1998. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype. Proc. Natl. Acad. Sci. USA. 95:714-718.
21. Calapai, G., et al. 1998. Effects of intracerebroventricular leptin administration on food intake, body-weight gain and diencephalic nitric oxide synthase activity in the mouse. Br. J. Pharmacol. 125:798-802.
22. Blundell, J.E. 1984. Serotonin and appetite. Neuropharmacology. 23:1537-1551.
23. Leibowitz, S.F. 1990. The role of 5-HT in eating disorders. Drugs. 39(Suppl. 3):33-48.
24. Garattini, S. 1995. Biological actions of drugs affecting 5-HT and eating. Obes. Res. 3(Suppl. 4):463S-470S.
25. Cerulli, J., Lomaestro, B.M., and Malone, M. 1998. Update on the pharmacotherapy of obesity. Ann. Pharmacother. 32:88-102.
26. Leibowitz, S.F., Weiss, G.F., and Shor-Posner, G. 1988. Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its feeding-suppressive action. Clin. Neuropharmacol. 11(Suppl. 1):S51-S71.
27. G-nitro-L-arginine, an inhibitor of nitric oxide synthase. Eur. J. Pharmacol. 255:51-55.
28. Harris, R.B., et al. 1998. A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. Endocrinology. 139:8-19.
29. DeSarro, G., et al. 1992. Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L-calcium channel in DBA/2 mice. Gen. Pharmacol. 23:1205-1216.
30. Bradford, M.M. 1976. A rapid method for quantitation of protein dye binding. Anal. Biochem. 72:248-254.
31. 2+-independent nitric oxide synthase. FEBS Lett. 291:145-149.
32. Squadrito, F., et al. 1991. Indolepyruvic acid, a tryptophan keto analogue, reduces food intake in obese Zucker rats. Neurosci. Res. Commun. 9:27-36.
33. Costa, A., Trainer, P., Besser, M., and Grossman, A. 1993. Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro. Brain Res. 605:187-192.
34. Haley, J.E., Wilcox, G.L., and Chapman, P.F. 1992. The role of nitric oxide in hippocampal long-term potentiation. Neuron. 8:211-216.
35. Calapai, G., and Caputi, A.P. 1996. Nitric oxide and drinking behaviour. Regul. Pept. 66:117-121.
36. Stricker-Krongrad, A., Beck, B., and Burlet, C. 1996. Nitric oxide mediates hyperphagia of obese Zucker rats: relation to specific changes in the microstructure of feeding behavior. Life Sci. 58:9-15.
37. Zhang, J., and Snyder, S.H. 1995. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:213-233.
38. Förstermann, U., and Kleinert, H. 1995. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch. Phamacol. 352:351-364.
39. Fukuto, J.M., and Chauduri, G. 1995. Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu. Rev. Pharmacol. Toxicol. 35:165-194.
40. Bredt, D.S., Hwang, P.M., and Snyder, S.H. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 347:768-770.
41. Dawson, T.M., Bredt, D.S., Fotuhi, M., Hwang, P.M., and Snyder, S.H. 1991. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA. 88:7797-7801.
42. Wu, G., and Morris, S.M. 1998. Argininc metabolism: nitric oxide and beyond. Biochem. J. 336:1-17.
43. Thim, L., et al. 1998. Purification and characterisation of a new hypothalamic satiety peptide, cocaine and amphetamine regulated transcript (CART), produced in yeast. FEBS Lett. 428:263-268.
44. Kristensen, P., et al. 1998. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:72-76.
45. Lambert, P., et al. 1998. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 29:293-298.
46. Squadrito, F., et al. 1994. Food deprivation increases brain nitric oxide synthase and depresses brain 5-HT levels in rats. Neuropharmacology. 33:83-86.
47. G-nitroarginine in brain in vitro and in vivo. Biochem. Biophys. Res. Commun. 176:1136-1141.
48. Bray, G.A. 1991. Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J. Nutr. 121:1146-1162.
49. Fuller, N.J., Stirling, D.M., Dunnett, S., Reynolds, B.P., and Ashwell, M. 1987. Decreased brown adipose tissue thermogenic activity following a reduction in brain 5-HT by intraventricular p-chlorophenylalanine. Biosci. Rep. 7:121-127.
50. Leibowitz, S. 1986. Brain monoamines and peptides: role in the control of eating behavior. Fed. Proc. 45:1396-1403.
51. Nathan, C., and Roland, Y. 1990. Pharmacological treatments that affect CNS activity: serotonin. Ann. NY Acad. Sci. 600:277-296.
52. Lawton, C.L., and Blundell, J.E. 1993. 5-HT manipulation and dietary choice: variable carbohydrate (Polycose) suppression demonstrated only under specific experimental conditions. Psychopharmacology (Berl.) 112:375-382.
53. Simansky, K.J. 1996. Serotoninergic control of the organization of feeding and satiety. Behav. Brain Res. 73:37-42.
54. Sakaguchi, T., and Bray, G.A. 1989. Effect of norepinephrine, 5-HT and tryptophan on the firing rate of sympathetic nerves. Brain Res. 492:271-280.
55. Shannon, N.J., Gunnet, J.W., and Moore, K.E. 1986. A comparison of biochemical indices 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus. J. Neurochem. 47:958-965.
56. Kalra, S.P., et al. 1999. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:68-100.